Dominique Helley

Paris, 75015, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Bleeding, thrombosis, and anti-Xa monitoring in danaparoid-treated patients with suspected heparin-induced thrombocytopenia: a retrospective single-center study.

Bleeding, thrombosis, and anti-Xa monitoring in danaparoid-treated patients with suspected heparin-induced thrombocytopenia: a retrospective single-center study.

Journal: Haematologica

Published: May 23, 2026

Circulating Biomarkers of Vascular Regeneration are not Associated with Residual Pulmonary Vascular Obstruction after Pulmonary Embolism: A Retrospective Observational Biomarker Study.

Circulating Biomarkers of Vascular Regeneration are not Associated with Residual Pulmonary Vascular Obstruction after Pulmonary Embolism: A Retrospective Observational Biomarker Study.

Journal: Stem cell reviews and reports

Published: February 25, 2026

Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study.

Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study.

Journal: Thrombosis and haemostasis

Published: November 25, 2025

Whole PROC Gene Sequencing to Explain Genetically Unresolved Protein C Deficiencies.

Whole PROC Gene Sequencing to Explain Genetically Unresolved Protein C Deficiencies.

Journal: Thrombosis and haemostasis

Published: August 11, 2025

Multiple thrombosis in a 54-year-old man

Multiple thrombosis in a 54-year-old man

Journal: La Revue de medecine interne

Published: July 03, 2025

Circulating CD34+ Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism.

Circulating CD34+ Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism.

Journal: Stem cell reviews and reports

Published: March 06, 2025

Evaluation of an IgG anti-PF4/H chemiluminescent immunoassay in the diagnosis of heparin-induced thrombocytopenia.

Evaluation of an IgG anti-PF4/H chemiluminescent immunoassay in the diagnosis of heparin-induced thrombocytopenia.

Journal: Blood vessels, thrombosis & hemostasis

Published: March 04, 2025

Cirrhotic Patients Exhibit Remarkable Vascular Regenerative Profile One Month after Liver Transplantation.

Cirrhotic Patients Exhibit Remarkable Vascular Regenerative Profile One Month after Liver Transplantation.

Journal: Stem cell reviews and reports

Published: September 24, 2024

Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic.

Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic.

Journal: Research and practice in thrombosis and haemostasis

Published: September 19, 2024

Implementation of edoxaban anti-Xa activity assay in a hospital laboratory and evaluation of its analytical performance

Implementation of edoxaban anti-Xa activity assay in a hospital laboratory and evaluation of its analytical performance

Journal: Annales de biologie clinique

Published: September 06, 2024

Interference of oral anti-Xa anticoagulants during monitoring of unfractionated heparin treatments: practical and future attitudes

Interference of oral anti-Xa anticoagulants during monitoring of unfractionated heparin treatments: practical and future attitudes

Journal: Annales de biologie clinique

Published: June 04, 2024

Massive hemoptysis: A normal platelet count may not be enough.

Massive hemoptysis: A normal platelet count may not be enough.

Journal: Respiratory medicine and research

Published: May 07, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026